Loading...
Docoh

Lundbeckfond Invest A/S

Filed: 13 Feb 18, 7:00pm
CUSIP No. 84833T103  13G  Page 10 of 12 Pages

 

EXHIBIT 1

Pursuant to Rule13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Spero Therapeutics, Inc.

Date: February 13, 2018

 

LUNDBECKFOND INVEST A/S
By: 

*

Name: Lene Skole
Title: Chief Executive Officer &Attorney-in-Fact

By:

 

*

Name: Mette Kirstine Agger
Title:Attorney-in-Fact
LENE SKOLE

/s/ Lene Skole

CASPER BREUM

/s/ Casper Breum


CUSIP No. 84833T103  13G  Page 11 of 12 Pages

 

/s/ Lene Skole

LENE SKOLE
*Asattorney-in-fact for Lundbeckfond Invest A/S.

/s/ Mette Kirstine Agger

METTE KIRSTINE AGGER
*Asattorney-in-fact for Lundbeckfond Invest A/S.

 

*This Schedule 13G was executed by Lene Skole and Mette Kristine Agger on behalf of the entity listed above, as indicated, pursuant to that certain Power of Attorney, a copy of which is attached to this Schedule 13G as Exhibit 2.